Medtronic Investing Cash Flow decreased by 46.7% to -$719.00M in Q2 2025 compared to the prior quarter. Year-over-year, this metric declined by 177.6%, from -$259.00M to -$719.00M.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q1 '22 | Q2 '22 | Q1 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$784.00M | -$1.95B | -$1.59B | -$2.06B | -$475.00M | -$539.00M | -$65.00M | -$1.07B | -$696.00M | -$259.00M | -$942.00M | -$246.00M | -$490.00M | -$719.00M |
| QoQ Change | — | -148.3% | +18.6% | -29.7% | +76.9% | -13.5% | +87.9% | <-999% | +34.7% | +62.8% | -263.7% | +73.9% | -99.2% | -46.7% |
| YoY Change | — | — | -102.2% | — | — | +66.0% | — | +48.1% | -46.5% | +51.9% | <-999% | +76.9% | +29.6% | -177.6% |